Insider Actions for Sorrento Therapeutics Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 09/29/2021 |
Henry H. Ji See Remarks; Director |
10,000 | Derivative/Non-derivative trans. at $4 per share. | 40,000 |
| 09/27/2021 |
Kim D. Janda Director |
42,357 | Disposition at $8.02 per share. | 339,703 |
| 09/27/2021 |
Kim D. Janda Director |
7,357 | Derivative/Non-derivative trans. at $3.57 per share. | 26,264 |
| 09/27/2021 |
Kim D. Janda Director |
35,000 | Derivative/Non-derivative trans. at $1.8 per share. | 63,000 |
| 09/13/2021 |
Kim D. Janda Director |
8,000 | Disposition at $8.04 per share. | 64,320 |
| 09/13/2021 |
Kim D. Janda Director |
8,000 | Derivative/Non-derivative trans. at $3.5 per share. | 28,000 |
| 09/03/2021 |
Robin L. Smith Director |
100,000 | Derivative/Non-derivative trans. at $4.89 per share. | 489,000 |
| 09/03/2021 |
Robin L. Smith Director |
75,000 | Derivative/Non-derivative trans. at $3.95 per share. | 296,250 |
| 04/12/2021 |
Kim D. Janda Director |
1,900 | Disposition at $6.97 per share. | 13,243 |
| 04/12/2021 |
Kim D. Janda Director |
1,900 | Derivative/Non-derivative trans. at $3.5 per share. | 6,650 |
| 03/16/2021 |
Najjam Asghar Chief Financial Officer |
56,974 | Award at $0 per share. | 0 |
| 12/16/2020 |
Dorman Followwill Director |
1,000 | Disposition at $7.14 per share. | 7,140 |
| 11/11/2020 |
Dorman Followwill Director |
1,000 | 0 | |
| 03/05/2020 |
Robin L. Smith Director |
40,000 | Acquisition at $2.27 per share. | 90,800 |
| 09/13/2018 |
Ally Bridge Group HK Ltd |
78,677 | Disposition at $4.92 per share. | 387,090 |
| 09/13/2018 |
Ally Bridge Group HK Ltd |
29,137 | Disposition at $5.01 per share. | 145,976 |
